A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer.

[1]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[2]  L. Livi,et al.  Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[3]  John J Spinelli,et al.  Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. , 2005, Journal of the National Cancer Institute.

[4]  Melania Pintilie,et al.  Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. , 2004, The New England journal of medicine.

[5]  Barbara L. Smith,et al.  Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. , 2004, The New England journal of medicine.

[6]  S. Schnitt,et al.  Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. , 2004, International journal of radiation oncology, biology, physics.

[7]  B. Goh,et al.  Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy , 2004, Cancer.

[8]  S. Steinberg,et al.  Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy , 2003, Cancer.

[9]  Umberto Veronesi,et al.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.

[10]  B. E. F. Isher,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .

[11]  Norman Wolmark,et al.  Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  T. Whelan,et al.  Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer , 2002 .

[13]  I. Barillot,et al.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. , 2001, The New England journal of medicine.

[14]  G. Hortobagyi,et al.  Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. , 2001, Journal of Clinical Oncology.

[15]  J. Isola,et al.  Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study , 2001, British Journal of Cancer.

[16]  R. Gelber,et al.  Tubular carcinoma of the breast: Prognosis and response to adjuvant systemic therapy , 2001, ANZ journal of surgery.

[17]  Richard Sylvester,et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2000, Journal of the National Cancer Institute.

[18]  S J Schnitt,et al.  Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  L. Tabár,et al.  10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  B. Rasmussen,et al.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial , 1999, The Lancet.

[21]  G M Clark,et al.  Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  K. Zedeler,et al.  Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy , 1997 .

[23]  D. Wartenberg,et al.  The importance of histologic type on breast cancer survival. , 1997, Journal of clinical epidemiology.

[24]  T. Whelan,et al.  Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an Update , 1996 .

[25]  David C. Smith,et al.  Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial , 1996, The Lancet.

[26]  R. Arriagada,et al.  Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  J. Gazet,et al.  The importance of the resection margin in conservative surgery for breast cancer. , 1996, European Journal of Surgical Oncology.

[28]  Anthony Howell,et al.  Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. , 1995, The New England journal of medicine.

[29]  Mike Clarke,et al.  EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS , 1995 .

[30]  C. Redmond,et al.  Pathologic findings from the national surgical adjuvant breast project protocol B‐06 10‐year pathologic and clinical prognostic discriminants , 1993, Cancer.

[31]  S. Paik,et al.  Pathologic findings from the national surgical adjuvant breast project (protocol 6) I. Intraductal carcinoma (DCIS) , 1986, Cancer.

[32]  G. Peters,et al.  Tubular carcinoma of the breast. Clinical pathologic correlations based on 100 cases. , 1981, Annals of surgery.

[33]  A. Courdi,et al.  Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. , 2005, International journal of radiation oncology, biology, physics.

[34]  L. Norton,et al.  Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  B. Haffty,et al.  Negative margin status improves local control in conservatively managed breast cancer patients. , 2000, The cancer journal from Scientific American.

[36]  T. Nakajima,et al.  Surgical margin and breast recurrence after breast-conserving therapy. , 1999, Oncology reports.

[37]  D. Schultz,et al.  Outcome of conservative therapy for invasive breast cancer by histologic subtype. , 1992, International journal of radiation oncology, biology, physics.

[38]  H. Mouridsen,et al.  Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. , 1992, Journal of the National Cancer Institute. Monographs.